Bayer reduces combined sales estimate for its experimental drugs Medical Dialogues Bureau8 Dec 2018 9:20 AM ISTFRANKFURT: Germany's Bayer, which acquired seed company, Monsanto, this year, reduced its combined sales estimate for its most promising experimental...
FDA declines to approve Allergan's Esmya Medical Dialogues Bureau24 Aug 2018 9:45 AM ISTAllergan Plc said U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids,...